Welcome to our dedicated page for Micron Solutions news (Ticker: MICR), a resource for investors and traders seeking the latest updates and insights on Micron Solutions stock.
Micron Solutions, Inc. (OTCQB: MICR) is a diversified contract manufacturing organization based in Fitchburg, Massachusetts. Through its subsidiary, Micron Products, Inc., the company specializes in producing highly engineered components utilizing precision machining and injection molding technologies. Micron Solutions is a market leader in manufacturing medical device components, sensors for disposable electrophysiological sensors, and components for military, law enforcement, industrial, and automotive applications. The company's strategic focus is on building a best-in-class contract manufacturer with a specialized expertise in plastic injection molding and precision machining for medical devices.
Micron Solutions, Inc. (OTCQB: MICR) reported financial results for Q4 and fiscal year 2022, showing a significant improvement in net sales and gross margin despite a net loss. Q4 net sales rose to $5.55 million, a 26.9% increase from Q4 2021. The net loss decreased to $222,563 from $928,491 in Q4 2021, with gross margin improving to 10.8%. For the fiscal year, net sales reached $22.56 million, a 10.6% increase, although a net loss of $1.29 million was reported compared to a net income of $1.73 million in 2021. Gross margin improved to 12.6%. CEO Bill Laursen indicated ongoing challenges due to macroeconomic factors and supply chain issues.
Micron Solutions, Inc. (OTCQB: MICR) reported its financial results for Q3 2022, showing an 18.5% increase in net sales, totaling $5,790,966 compared to $4,884,881 in Q3 2021. The net loss decreased to ($139,423) from ($472,113) year-over-year, with gross margin rising to 16.3% from 5.3%. Adjusted EBITDA turned positive at $140,000, compared to a loss of ($122,000) in the same quarter last year. The company’s focus on the medical market has strengthened their performance amidst economic challenges.
Micron Solutions, Inc. (OTCQB: MICR) reported a significant 21.3% increase in net sales for Q2 2022, totaling $6,536,326, up from $5,389,735 in Q2 2021, driven by a strong medical market performance. However, the Company faced a net loss of $210,797 compared to a net income of $3,012,992 in the prior year, which included a substantial gain from a sale/leaseback. Gross margin improved to 13.9% from 8.1% year-over-year, while adjusted EBITDA was $106,000 compared to a loss of $407,000 in Q1 2022.
Micron Solutions, Inc. (OTCQB: MICR) reported financial results for Q1 2022, revealing a significant 18.7% drop in net sales to $4.68 million compared to $5.76 million in Q1 2021. A net loss of $720,355 contrasted sharply with a net income of $114,939 in the previous year. Gross margin also fell to 8.5% from 16.1%. However, sales increased by 7% from Q4 2021 due to heightened customer activity. CEO Bill Laursen highlighted the trends pointing to recovery post-COVID, alongside ongoing investments to improve customer relations and efficiency.
Micron Solutions, Inc. (OTCQB: MICR) reported Q4 and fiscal year 2021 results, showing a 22.1% decline in Q4 net sales ($4.4M) and a net loss of ($928K). Annual net sales fell 2.1% to $20.4M, with a net income rise to $1.7M. Gross margins decreased significantly, 5.1% in Q4 and 9.1% for the year. The company announced a $1M stock repurchase program and an amended Credit Facility with Berkshire Bank, enhancing liquidity. Despite challenges, Micron sees growth opportunities as manufacturing shifts back to the U.S.
Micron Solutions, Inc. (OTCQB: MICR) has appointed Mr. Martin Johnson as the new Executive Vice President of Sales and Strategy. Johnson brings over 30 years of experience in Technology and Business Development within the Injection Molding industry. His previous roles include senior positions at major contract manufacturers. CEO Bill Laursen expressed optimism about Johnson's addition, highlighting the potential for enhanced customer value through strategic growth and technical innovation. The company focuses on precision machining and contract manufacturing for various applications, including medical and military sectors.
Micron Solutions, Inc. (OTCQB: MICR) has been awarded $247,800 in grant funding from the Commonwealth of Massachusetts’ Workforce Training Fund Program. This funding aims to enhance the company’s manufacturing capabilities by creating an engaged workforce and fostering a Lean Culture. With 113 associates employed in Fitchburg, Massachusetts, Micron is committed to operational excellence. The company has been a longstanding employer in the area and continues to prioritize skill development for its employees.
FAQ
What is the market cap of Micron Solutions (MICR)?
What is Micron Solutions, Inc. known for?
What is the strategic focus of Micron Solutions?
What recent proposal did Micron Solutions announce?
How does Micron Solutions plan to enact the Stock Splits?
What is the primary purpose of the Stock Splits for Micron Solutions?
How does Micron Solutions intend to treat shareholders who hold shares in 'street name'?
What factors did the Board consider in approving the proposal for Stock Splits?
From where does Micron Solutions expect to fund the Cash Payment and costs related to the Stock Splits?
What is the Company's plan following the enactment of the Stock Splits?